RT Journal Article
SR Electronic
T1 Automating the generation of antimicrobial resistance surveillance reports: a proof-of-concept study in seven hospitals in seven countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.27.20072025
DO 10.1101/2020.04.27.20072025
A1 Cherry Lim
A1 Thyl Miliya
A1 Vilada Chansamouth
A1 Myint Thazin Aung
A1 Abhilasha Karkey
A1 Prapit Teparrukkul
A1 Rahul Batra
A1 Lan Nguyen Phu Huong
A1 John Stelling
A1 Paul Turner
A1 Elizabeth Ashley
A1 Rogier H van Doorn
A1 Htet Naing Lin
A1 Clare Ling
A1 Soawapak Hinjoy
A1 Sopon Iamsirithaworn
A1 Susanna J Dunachie
A1 Tri Wangrangsimakul
A1 Viriya Hantrakun
A1 William Schilling
A1 Yen Lam Minh
A1 Tan Le Van
A1 Htay Htay Hlaing
A1 Mayfong Mayxay
A1 Manivanh Vongsouvath
A1 Buddha Basnyat
A1 Jonathan Edgeworth
A1 Sharon J Peacock
A1 Guy Thwaites
A1 Nicholas PJ Day
A1 Ben S Cooper
A1 Direk Limmathurotsakul
YR 2020
UL http://medrxiv.org/content/early/2020/05/01/2020.04.27.20072025.abstract
AB Background Reporting cumulative antimicrobial susceptibility testing data on a regular basis is crucial to inform antimicrobial resistance (AMR) action plans at local, national and global levels. However, analysing data and generating a report are time-consuming and often require trained personnel. We illustrate the development and utility of an offline, open-access and automated tool that can support the generation of AMR surveillance reports promptly at the local level.Methods An offline application to generate standardized AMR surveillance reports from routinely available microbiology and hospital data files was written in the R programming language. The application can be run by a double-click on the application file without any further user input. The data analysis procedure and report content were developed based on the recommendations of the World Health Organization Global Antimicrobial Resistance Surveillance System (WHO GLASS). The application was tested in Microsoft Windows 10 and 7 using open-access example data sets. We then independently tested the application in seven hospitals in Cambodia, Lao People’s Democratic Republic (PDR), Myanmar, Nepal, Thailand, the United Kingdom, and Vietnam.Findings We developed the AutoMated tool for Antimicrobial resistance Surveillance System (AMASS), which can support clinical microbiology laboratories to analyse their microbiology and hospital data files (in CSV or Excel format) onsite and promptly generate AMR surveillance reports (in PDF and Excel formats). The data files could be those exported from WHONET and/or other laboratory information systems. The automatically generated reports contain only summary data without patient identifiers. The AMASS application is downloadable from www.amass.website. The participating hospitals tested the application and deposited their AMR surveillance reports in an open-access data repository.Interpretation The AMASS application can be a useful tool to support the generation and sharing of AMR surveillance reports.Funding Mahidol Oxford Tropical Medicine Research Unit (MORU) is funded by the Wellcome Trust (Grant no. 106698/Z/14/Z). Oxford University Clinical Research Unit (OUCRU) is funded by the Wellcome Trust (Grant no. 106680/B/14/Z). The investigators are funded by the Wellcome Trust (CL is funded by a Training Research Fellowship [Grant no. 206736] and DL is funded by an Intermediate Training Fellowship [Grant no. 101103]). BSC is funded by the UK Medical Research Council and Department for International Development (Grant no. MR/K006924/1). The funder has no role in the design and conduct of the study, data collection, or analysis and interpretation of the data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMahidol Oxford Tropical Medicine Research Unit (MORU) is funded by the Wellcome Trust (Grant no. 106698/Z/14/Z). Oxford University Clinical Research Unit (OUCRU) is funded by the Wellcome Trust (Grant no. 106680/B/14/Z). The investigators are funded by the Wellcome Trust (CL is funded by a Training Research Fellowship [Grant no. 206736] and DL is funded by an Intermediate Training Fellowship [Grant no. 101103]). BSC is funded by the UK Medical Research Council and Department for International Development (Grant no. MR/K006924/1). The funder has no role in the design and conduct of the study, data collection, or analysis and interpretation of the data.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support this study are open-access in figshare at: https://doi.org/10.6084/m9.figshare.12000225.v1 https://doi.org/10.6084/m9.figshare.12000222.v1 https://doi.org/10.6084/m9.figshare.12000237.v1 https://doi.org/10.6084/m9.figshare.12000231.v1 https://doi.org/10.6084/m9.figshare.12000240.v1 https://doi.org/10.6084/m9.figshare.12000249.v1 https://doi.org/10.6084/m9.figshare.12000252.v1